{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:53:42Z","timestamp":1775210022244,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":95,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ymgme.2023.107565","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T17:57:47Z","timestamp":1680717467000},"page":"107565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pompe disease ascertained through The Lantern Project, 2018\u20132021: Next-generation sequencing and enzymatic testing to overcome obstacles to diagnosis"],"prefix":"10.1016","volume":"139","author":[{"given":"Lisa","family":"Sniderman King","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babi Ramesh Reddy","family":"Nallamilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhuri","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmanan","family":"Jagannathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinish","family":"Ramachander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Markind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Colzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2023.107565_bb0005","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2023.107565_bb0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107565_bb0015","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/ajmg.a.36110","article-title":"Timing of diagnosis of patients with Pompe disease: data from the Pompe registry","volume":"161A","author":"Kishnani","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2023.107565_bb0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2023.107565_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13023-019-1291-2","article-title":"The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe disease","volume":"15","author":"Bevilacqua","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2023.107565_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2023.107565_bb0035","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2023.107565_bb0040","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S1474-4422(21)00241-6","article-title":"Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial","volume":"20","author":"Diaz-Manera","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2023.107565_bb0045","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.3390\/ijms221810064","article-title":"Design and validation of a custom NGS panel targeting a set of lysosomal storage diseases candidate for NBS applications","volume":"22","author":"La Cognata","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2023.107565_bb0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/1678-4685-gmb-2018-0092","article-title":"Sensitivity, advantages, limitations, and clinical utility of targeted next-generation sequencing panels for the diagnosis of selected lysosomal storage disorders","volume":"42","author":"Malaga","year":"2019","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.ymgme.2023.107565_bb0055","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/acn3.649","article-title":"Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients","volume":"5","author":"Nallamilli","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymgme.2023.107565_bb0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/ahg.12319","article-title":"Impact of next-generation sequencing panels in the evaluation of limb-girdle muscular dystrophies","volume":"83","author":"Ozyilmaz","year":"2019","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.ymgme.2023.107565_bb0065","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.nmd.2018.03.011","article-title":"Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease","volume":"28","author":"Savarese","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2023.107565_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40478-014-0100-3","article-title":"MotorPlex provides accurate variant detection across large muscle genes both in single myopathic patients and in pools of DNA samples","volume":"2","author":"Savarese","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymgme.2023.107565_bb0075","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00415-016-8036-0","article-title":"Utility of a next-generation sequencing-based gene panel investigation in German patients with genetically unclassified limb-girdle muscular dystrophy","volume":"263","author":"Kuhn","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2023.107565_bb0080","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.spen.2012.09.008","article-title":"Update on the genetics of limb girdle muscular dystrophy","volume":"19","author":"Mitsuhashi","year":"2012","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2023.107565_bb0085","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS recommendations for the description of sequence variants: 2016 update","volume":"37","author":"den Dunnen","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2023.107565_bb0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107565_bb0095","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.31319","article-title":"Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience","volume":"160C","author":"Bali","year":"2012","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2023.107565_bb0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/humu.24148","article-title":"Update of the Pompe variant database for the prediction of clinical phenotypes: novel disease-associated variants, common sequence variants, and results from newborn screening","volume":"42","author":"de Faria","year":"2021","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2023.107565_bb0105","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5114\/fn.2021.109426","article-title":"Genetic analysis of muscular dystrophies: our experience in Mexico","volume":"59","author":"Escobar-Cedillo","year":"2021","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.ymgme.2023.107565_bb0110","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1002\/ajmg.a.38333","article-title":"Next generation deep sequencing corrects diagnostic pitfalls of traditional molecular approach in a patient with prenatal onset of Pompe disease","volume":"173","author":"Tsai","year":"2017","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2023.107565_bb0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.braindev.2018.05.001","article-title":"Interpretation of acid alpha-glucosidase activity in creatine kinase elevation: a case of Becker muscular dystrophy","volume":"40","author":"Oitani","year":"2018","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2023.107565_bb0120","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s10072-020-04896-3","article-title":"Tetraparesis and sensorimotor axonal polyneuropathy due to co-occurrence of Pompe disease and hereditary ATTR amyloidosis","volume":"42","author":"Zimmermann","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ymgme.2023.107565_bb0125","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ebiom.2019.03.048","article-title":"A genetic modifier of symptom onset in Pompe disease","volume":"43","author":"Bergsma","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymgme.2023.107565_bb0130","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/hmg\/3.7.1081","article-title":"A de novo 13 nt deletion, a newly identified C647W missense mutation and a deletion of exon 18 in infantile onset glycogen storage disease type II (GSDII)","volume":"3","author":"Huie","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2023.107565_bb0135","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1006\/bbrc.1998.8255","article-title":"Glycogen storage disease type II: identification of four novel missense mutations (D645N, G648S, R672W, R672Q) and two insertions\/deletions in the acid alpha-glucosidase locus of patients of differing phenotype","volume":"244","author":"Huie","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2023.107565_bb0140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2007.07.006","article-title":"Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II","volume":"92","author":"McCready","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107565_bb0145","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00415-009-5219-y","article-title":"Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutations","volume":"256","author":"Oba-Shinjo","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2023.107565_bb0150","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2012.05.004","article-title":"Transcriptional response to GAA deficiency (Pompe disease) in infantile-onset patients","volume":"106","author":"Palermo","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107565_bb0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.gene.2015.02.023","article-title":"Novel GAA mutations in patients with Pompe disease","volume":"561","author":"Turaca","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.ymgme.2023.107565_bb0160","doi-asserted-by":"crossref","first-page":"1001154","DOI":"10.3389\/fgene.2022.1001154","article-title":"Development of a clinically validated in vitro functional assay to assess pathogenicity of novel GAA variants in patients with Pompe disease identified via newborn screening","volume":"13","author":"Goomber","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2023.107565_bb0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2008.07.013","article-title":"Cardiac evaluation in children and adults with Pompe disease sharing the common c.-32-13T>G genotype rarely reveals abnormalities","volume":"275","author":"van der Beek","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2023.107565_bb0170","first-page":"19","article-title":"Chagasic cardiomyopathy and Pompe disease: case report","volume":"8","author":"de Morais","year":"2018","journal-title":"Am. J. Cardiovasc. Dis."},{"key":"10.1016\/j.ymgme.2023.107565_bb0175","article-title":"Late-onset Pompe disease manifests in the brain","volume":"20","author":"Finsterer","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2023.107565_bb0180","article-title":"Response: late-onset Pompe disease manifests in the brain","volume":"21","author":"Schneider","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2023.107565_bb0185","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ymgme.2019.05.007","article-title":"White matter lesions in treated late onset Pompe disease are not different to matched controls","volume":"127","author":"Schneider","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107565_bb0190","first-page":"78","article-title":"Early is better? A new algorithm for early diagnosis in late onset Pompe disease (LOPD)","volume":"32","author":"Toscano","year":"2013","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymgme.2023.107565_bb0195","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.nmd.2019.06.011","article-title":"The nature of respiratory muscle weakness in patients with late-onset Pompe disease","volume":"29","author":"Spiesshoefer","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2023.107565_bb0200","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.nmd.2020.03.003","article-title":"Language, speech, and oromotor function in children with Pompe disease","volume":"30","author":"Su","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2023.107565_bb0205","first-page":"55","article-title":"Rapidly progressive white matter involvement in early childhood: the expanding phenotype of infantile onset Pompe?","volume":"39","author":"Broomfield","year":"2018","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2023.107565_bb0210","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12883-017-0983-2","article-title":"The humanistic burden of Pompe disease: are there still unmet needs? A systematic review","volume":"17","author":"Schoser","year":"2017","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ymgme.2023.107565_bb0215","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1080\/14737175.2020.1825943","article-title":"Diagnostic challenges in metabolic myopathies","volume":"20","author":"Angelini","year":"2020","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.ymgme.2023.107565_bb0220","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.4081\/ejtm.2021.9798","article-title":"Exercise, nutrition and enzyme replacement therapy are efficacious in adult Pompe patients: report from EPOC consortium","volume":"31","author":"Angelini","year":"2021","journal-title":"Eur. J. Transl. Myol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223001956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223001956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:53:35Z","timestamp":1761090815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223001956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1096719223001956"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107565","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pompe disease ascertained through The Lantern Project, 2018\u20132021: Next-generation sequencing and enzymatic testing to overcome obstacles to diagnosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107565"}}